Back to results
US 2017/0320933 A1Published application
Cytokine-based fusion proteins for treatment of immune disorders
AssigneeEast Carolina University
InventorMark D. Mannie
Life of this patent
Estimating the term…
Abstract
The present invention provides fusion proteins including an autoimmune antigen, an allergen antigen or an alloantigen, and an anti-inflammatory cytokine. Compositions and methods including the fusion proteins are also provided.
Claims4
A method of modulating an immune response comprising administering at least one fusion protein in an amount sufficient to elicit a tolerogenic response, wherein said fusion protein comprises an autoimmune antigen, an allergen antigen or an alloantigen, and an anti-inflammatory cytokine.
Dependencies are inferred from the claim text.